Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
 
VC-funded Company:


Obsidian Therapeutics
1030 Massachusetts Avenue, Suite 400
Cambridge, MA 02138
http://obsidiantx.com/

Obsidian Therapeutics is a biotechnology company developing next-generation cell and gene therapies with pharmacologic operating systems. Based upon founding work on destabilizing domains by Professor Thomas Wandless, a leading researcher in chemical and systems biology, Obsidian's lead programs are CAR-T products that incorporate controllable functions for enhanced safety and efficacy. Obsidian was founded in 2015 by Atlas Venture and is funded by a strong syndicate of venture investors.

Key Contact
NameTitleE-Mail
Michael GilmanCEO


Funding Events
DateAmountTypeInvestors
12/06/17$49,500,000Series A Alexandria Real Estate Equities
Amgen Ventures
Atlas Venture
Google Ventures  
ShangPharma Investment Group
Takeda Ventures
Vertex Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2017 Massinvestor, Inc.